The Presidential Advisory Council on HIV/AIDS (#PACHA) met in Houston, Texas, on March 27 and 28, 2024. Among the topics PACHA explored during our 80th full Council meeting were the response to rising #syphilis rates and work to #endHIVepidemic in Texas. Read the article for more details.
Office of Infectious Disease and HIV/AIDS Policy
Government Administration
Washington, D.C. 5.104 followers
Working toward a world free of infectious disease.
About us
The Office of Infectious Disease and HIV/AIDS Policy (OIDP) is located in the Office of the Assistant Secretary for Health (ASH), Office of the Secretary (OS), U.S. Department of Health and Human Services (HHS). Our mission is to provide strategic leadership and management, while encouraging collaboration, coordination, and innovation among federal agencies and stakeholders to reduce the burden of infectious diseases. OIDP works with federal and non-federal stakeholders to develop, coordinate, and implement national strategies and initiatives to prevent infectious diseases. Some of the topics addressed by our working groups and national strategies include: -Antibiotic resistance -Blood and tissue safety and availability -HIV and AIDS -Sexually transmitted infections -Tick-borne diseases -Vaccines and immunization -Viral hepatitis
- Website
-
https://www.hhs.gov/oidp/index.html
External link for Office of Infectious Disease and HIV/AIDS Policy
- Industry
- Government Administration
- Company size
- 5,001-10,000 employees
- Headquarters
- Washington, D.C.
Updates
-
Our PACE program has a new name! The rebrand represents the expansion of the program’s focus to include syndemics and health equity, as well as coverage of additional priority jurisdictions of the Ending the HIV Epidemic in the U.S. (EHE) initiative. Get more details in this short article.
PACE Program Rebranded as OIDP Engagement Teams
Office of Infectious Disease and HIV/AIDS Policy on LinkedIn
-
May is #HepatitisAwarenessMonth, an important time to highlight our commitment to combating viral hepatitis in the U.S. The Viral Hepatitis National Strategic Plan outlines a vision to prevent new infections, ensure everyone knows their status, and provide high-quality care and treatment, free from stigma. The plan includes 5 major goals, objectives, and strategies to achieve these goals. Read the Plan here: https://brnw.ch/21wJPUP #HepAware24
-
During National Women’s Health Week, OIDP Director Kaye Hayes talks sexual health and wellness, and highlights the importance of STI testing and prevention. #NWHW #NWHW2024 #GetTested #SexualHealth
-
Taking care of a person's mental health is just as important as taking care of their physical health. Health conditions like HIV can exacerbate any mental health conditions a person has. How can you and your organization help people with HIV address mental health conditions? Encourage individuals to seek support and discuss treatment options with their healthcare provider. Also, let them know it's okay to seek support. You can find more information about HIV and mental health at https://brnw.ch/21wJNJ2
-
To support the nation in making strides toward reaching viral hepatitis elimination by 2030, the HHS Office of Infectious Disease and HIV/AIDS Policy (OIDP) has been facilitating conversations about the development and adoption of clinically meaningful and feasible state-level viral hepatitis quality measures for Medicaid. The Medicaid Adult Core Set does not currently include any viral hepatitis measures. Since Medicaid provides coverage for a disproportionate share of people with hepatitis B and hepatitis C, one way to support translation of recommendations to clinical practice is through establishment of quality measures. OIDP is seeking public comment on a proposed hepatitis C screening and treatment initiation measure for adoption in the Adult Core Set. Feedback due June 7, 2024. OIDP has renamed the Prevention through Active Community Engagement (PACE) program as OIDP Engagement Teams. The new name represents the expansion of the program’s focus to include syndemics and health equity, as well as coverage of additional priority jurisdictions of the Ending the HIV Epidemic in the U.S. (EHE) initiative. A generative AI internship with the OIDP’s HIVgov program is now open. The intern will work with senior federal leadership to assess and expand one of the most extensive HIV communications programs in the country, and will gain work experience in a fast-paced, team-based work environment with exposure to a wide range of health policy issues. During the recent Biomedical HIV Prevention Summit hosted by NMAC in Seattle, Washington, the HIVgov team spoke with leaders in the HIV field who gathered to discuss the data, research, and science surrounding efforts to end the HIV epidemic. HIVgov’s Director, Miguel Gomez, spoke with NMAC leadership about the conference. Visit the website to read the full blogs! #HepatitisC #HIV #Internship
-
Save the date: The 25th Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) public meeting will take place May 21-22, 2024. The two-day meeting is open to the public and will be held virtually. Register: https://brnw.ch/21wJLeu __ PACCARB supports and evaluates U.S. government activities that are focused on the impact of antimicrobial resistance (AMR) on human health, animal health, and environmental health.
-
A generative AI internship with Office of Infectious Disease and HIV/AIDS Policy's HIVgov program is now open. The intern will work with senior federal leadership to assess and expand one of the most extensive HIV communications programs in the country. Read this brief article for details:
HIV.gov Generative AI Internship Opportunity
Office of Infectious Disease and HIV/AIDS Policy on LinkedIn
-
We're one week away from National Asian & Pacific Islander HIV/AIDS Awareness Day! Get your #NAPIHAAD resources at https://brnw.ch/21wJIYs
-
Office of Infectious Disease and HIV/AIDS Policy is seeking input on potential viral #hepatitis quality measures for implementation at the state and territory level. Quality measures are tools to monitor and improve the quality of health care. Scaling up viral hepatitis screening, linkage to care, and access to treatment will ultimately reduce transmission, incidence of new infections, prevent liver cancer and mortality, and allow the U.S. to make strides in reaching viral hepatitis elimination by 2030. Submit your comments to OIDPViralHepatitis@hhs.gov by 5 p.m. EST on Friday, June 7, 2024. #HepatitisAwarenessMonth #HepAware2024